Purchases and Sales Made in Q4 2022 in Nuvectis Pharma, Inc. (NVCT)
This table provides information about the institutional ownership of Nuvectis Pharma, Inc. (NVCT) during Q4 2022. The information is specifically focused on institutions that hold shares of Nuvectis Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
169K+ 623.66% |
$1.13M - $1.31M
|
196K
$920K
|
|
|
Feb 15, 2023
Q4 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
12.4KNew |
$83.2K - $96.1K
|
12.4K
$58.4K
|
|
|
Jan 27, 2023
Q4 2022
|
Baldwin Brothers LLC
|
BUY
|
- |
300+ 0.23% |
$2.01K - $2.32K
|
133K
$627K
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
100+ 49.75% |
$670 - $774
|
301
$1.41K
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
12New |
$80.4 - $92.9
|
12
$56.4
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 4.17% |
$6.7 - $7.74
|
25
$118
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-73- 0.23% |
$489 - $565
|
31.4K
$147K
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-2.69K- 66.46% |
$18K - $20.8K
|
1.36K
$6.39K
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-3.84K- 27.44% |
$25.7K - $29.7K
|
10.2K
$47.8K
|
|
|
Feb 14, 2023
Q4 2022
|
Sabby Management, LLC
Upper Saddle River, NJ |
SELL
|
- |
-45.5K- 7.19% |
$305K - $352K
|
587K
$2.76M
|